by Paul | Oct 16, 2017 | News
Despite its numerous risks and dangers, Johnson & Johnson decided to move forward towards expanding the market for the antidiabetes drug Invokana. The controversial medication is, in fact, associated with many serious side effects such as kidney failure, increased...
by Paul | Oct 6, 2017 | News
A new wave of Abilify lawsuits was filed as Bristol-Myers Squibb’s latest antipsychotic medication was found to increase the risk of type-2 diabetes in children. According to a 2013 study published in the clinical journal JAMA Psychiatry, the overprescription of...
by Paul | Oct 2, 2017 | News
Ella Ebaugh, 51, received a $57 million settlement after filing a Transvaginal Mesh lawsuit against Ethicon and Johnson & Johnson. The plaintiff from Pennsylvania sued the two giant corporations after being implanted with the device that caused her to suffer from...
by Paul | Sep 26, 2017 | News
The United States District Court for the District of Minnesota issued a conference to oversee the current status of the Fluoroquinolones Antibiotics MDL (Levaquin, Avelox and Cipro). Centralized by the U.S. Judicial Panel on Multidistrict Litigation (JMPL) in August...
by Paul | Sep 20, 2017 | News
A new study found that the antidepressant effects of Abilify (aripiprazole) are so minimal that its risks significantly outweigh the alleged benefits. The medication manufactured by Bristol-Myers Squibb is one of the most controversial ones actually sold in the U.S....
by Paul | Jul 25, 2017 | News
After the Rheumatoid Arthritis (RA) drug Actemra (tocilizumab) has been linked to thousands of death cases, many victims decided to file a lawsuit. According to a study recently published by STAT, this innovative medication’s side...
